Bayer Signs Global Agreement for Alpharadin with Algeta
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 9 (Table of Contents)
Published: 9 Sep-2009
DOI: 10.3833/pdr.v2009.i9.1241 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Bayer and Algeta have entered into a deal to promote Algeta's novel alpha-ray emitting pharmaceutical based on radium-223 called Alpharadin™...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS